Skip to content
★ Sign in to follow
KB

Katrine Bosley

CEO
Editas Medicine, Inc.
Total declarations
51
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (49 ops.)
€6.1M

Latest filing published 10 Jan 2019 for Editas Medicine, Inc., €264k.

Filing timeline

BuySale
Katrine Bosley

Insider track record

Disclosed buys
0
Disclosed sells
49
Signal history

Katrine Bosley: trading record in brief

Katrine Bosley is a declared insider of Editas Medicine, Inc., with filings sourced from SEC (Form 4). The record holds 51 filings, for trades running from 8 February 2016 to 8 January 2019.

Every open-market trade on record is a sale: 49 sales worth €6.1M. In 2019 alone, the filings show no purchases and 1 sale.

Most recently, on 10 January 2019, the filings show an open-market sale worth €264k in Editas Medicine, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Katrine Bosley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations51 total

25 of 51 declarations